2018-2023 Global RNAi for Therapeutic Market Report (Status and Outlook)
- LP 2632908
- 136 Pages
- June 2018
- Medical Devices
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.
At present, global expenses concentrates in US and Europe, US takes 80% market share and Europe takes 5% market share. There is A Few R & D Company in the world and the market concentration is high. The top5 (expenses in RNAi for Therapeutic) companies are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics. The five companies occupy about 83% of the market share.
Over the next five years, LPI(LP Information) projects that RNAi for Therapeutic will register a 24.0% CAGR in terms of revenue, reach US$ 3580 million by 2023, from US$ 990 million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
siRNA
miRNA
Segmentation by application:
Cancer
Cardiovascular
HBV
Other
We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global RNAi for Therapeutic market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of RNAi for Therapeutic market by identifying its various subsegments.
Focuses on the key global RNAi for Therapeutic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the RNAi for Therapeutic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of RNAi for Therapeutic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global RNAi for Therapeutic Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNAi for Therapeutic Market Size 2013-2023
2.1.2 RNAi for Therapeutic Market Size CAGR by Region
2.2 RNAi for Therapeutic Segment by Type
2.2.1 siRNA
2.2.2 miRNA
2.2.3 shRNA
2.3 RNAi for Therapeutic Market Size by Type
2.3.1 Global RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
2.3.2 Global RNAi for Therapeutic Market Size Growth Rate by Type (2013-2018)
2.4 RNAi for Therapeutic Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular
2.4.3 HBV
2.4.4 Other
2.5 RNAi for Therapeutic Market Size by Application
2.5.1 Global RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
2.5.2 Global RNAi for Therapeutic Market Size Growth Rate by Application (2013-2018)
3 Global RNAi for Therapeutic by Players
3.1 Global RNAi for Therapeutic Market Size Market Share by Players
3.1.1 Global RNAi for Therapeutic Market Size by Players (2016-2018)
3.1.2 Global RNAi for Therapeutic Market Size Market Share by Players (2016-2018)
3.2 Global RNAi for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNAi for Therapeutic by Regions
4.1 RNAi for Therapeutic Market Size by Regions
4.2 Americas RNAi for Therapeutic Market Size Growth
4.3 APAC RNAi for Therapeutic Market Size Growth
4.4 Europe RNAi for Therapeutic Market Size Growth
4.5 Middle East & Africa RNAi for Therapeutic Market Size Growth
5 Americas
5.1 Americas RNAi for Therapeutic Market Size by Countries
5.2 Americas RNAi for Therapeutic Market Size by Type
5.3 Americas RNAi for Therapeutic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC RNAi for Therapeutic Market Size by Countries
6.2 APAC RNAi for Therapeutic Market Size by Type
6.3 APAC RNAi for Therapeutic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe RNAi for Therapeutic by Countries
7.2 Europe RNAi for Therapeutic Market Size by Type
7.3 Europe RNAi for Therapeutic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa RNAi for Therapeutic by Countries
8.2 Middle East & Africa RNAi for Therapeutic Market Size by Type
8.3 Middle East & Africa RNAi for Therapeutic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global RNAi for Therapeutic Market Forecast
10.1 Global RNAi for Therapeutic Market Size Forecast (2018-2023)
10.2 Global RNAi for Therapeutic Forecast by Regions
10.2.1 Global RNAi for Therapeutic Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global RNAi for Therapeutic Forecast by Type
10.8 Global RNAi for Therapeutic Forecast by Application
11 Key Players Analysis
11.1 Alnylam Pharmaceuticals
11.1.1 Company Details
11.1.2 RNAi for Therapeutic Product Offered
11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Alnylam Pharmaceuticals News
11.2 Arbutus Biopharma (Tekmira)
11.2.1 Company Details
11.2.2 RNAi for Therapeutic Product Offered
11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Arbutus Biopharma (Tekmira) News
11.3 Arrowhead
11.3.1 Company Details
11.3.2 RNAi for Therapeutic Product Offered
11.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Arrowhead News
11.4 Dicerna Pharmaceuticals
11.4.1 Company Details
11.4.2 RNAi for Therapeutic Product Offered
11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Dicerna Pharmaceuticals News
11.5 Mirna Therapeutics
11.5.1 Company Details
11.5.2 RNAi for Therapeutic Product Offered
11.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Mirna Therapeutics News
11.6 Quark Pharmaceuticals
11.6.1 Company Details
11.6.2 RNAi for Therapeutic Product Offered
11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Quark Pharmaceuticals News
11.7 RXi Pharmaceuticals
11.7.1 Company Details
11.7.2 RNAi for Therapeutic Product Offered
11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 RXi Pharmaceuticals News
11.8 Silence Therapeutics
11.8.1 Company Details
11.8.2 RNAi for Therapeutic Product Offered
11.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Silence Therapeutics News
11.9 Benitec Biopharma
11.9.1 Company Details
11.9.2 RNAi for Therapeutic Product Offered
11.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Benitec Biopharma News
11.10 miRagen Therapeutics
11.10.1 Company Details
11.10.2 RNAi for Therapeutic Product Offered
11.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 miRagen Therapeutics News
11.11 Sylentis
11.12 Gradalis
11.13 Sirnaomics
11.14 Silenseed
12 Research Findings and Conclusion
Table Product Specifications of RNAi for Therapeutic
Figure RNAi for Therapeutic Report Years Considered
Figure Market Research Methodology
Figure Global RNAi for Therapeutic Market Size Growth Rate 2013-2023 ($ Millions)
Table RNAi for Therapeutic Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of siRNA
Table Major Players of miRNA
Table Major Players of shRNA
Table Market Size by Type (2013-2018) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
Figure Global RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
Figure Global siRNA Market Size Growth Rate
Figure Global miRNA Market Size Growth Rate
Figure Global shRNA Market Size Growth Rate
Figure RNAi for Therapeutic Consumed in Cancer
Figure Global RNAi for Therapeutic Market: Cancer (2013-2018) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure RNAi for Therapeutic Consumed in Cardiovascular
Figure Global RNAi for Therapeutic Market: Cardiovascular (2013-2018) ($ Millions)
Figure Global Cardiovascular YoY Growth ($ Millions)
Figure RNAi for Therapeutic Consumed in HBV
Figure Global RNAi for Therapeutic Market: HBV (2013-2018) ($ Millions)
Figure Global HBV YoY Growth ($ Millions)
Figure RNAi for Therapeutic Consumed in Other
Figure Global RNAi for Therapeutic Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
Figure Global RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
Figure Global RNAi for Therapeutic Market Size in Cancer Growth Rate
Figure Global RNAi for Therapeutic Market Size in Cardiovascular Growth Rate
Figure Global RNAi for Therapeutic Market Size in HBV Growth Rate
Figure Global RNAi for Therapeutic Market Size in Other Growth Rate
Table Global RNAi for Therapeutic Revenue by Players (2016-2018) ($ Millions)
Table Global RNAi for Therapeutic Revenue Market Share by Players (2016-2018)
Figure Global RNAi for Therapeutic Revenue Market Share by Players in 2017
Table Global RNAi for Therapeutic Key Players Head office and Products Offered
Table RNAi for Therapeutic Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global RNAi for Therapeutic Market Size by Regions 2013-2018 ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share by Regions 2013-2018
Figure Global RNAi for Therapeutic Market Size Market Share by Regions 2013-2018
Figure Americas RNAi for Therapeutic Market Size 2013-2018 ($ Millions)
Figure APAC RNAi for Therapeutic Market Size 2013-2018 ($ Millions)
Figure Europe RNAi for Therapeutic Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa RNAi for Therapeutic Market Size 2013-2018 ($ Millions)
Table Americas RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table Americas RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)
Figure Americas RNAi for Therapeutic Market Size Market Share by Countries in 2017
Table Americas RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table Americas RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
Figure Americas RNAi for Therapeutic Market Size Market Share by Type in 2017
Table Americas RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Americas RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
Figure Americas RNAi for Therapeutic Market Size Market Share by Application in 2017
Figure United States RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Canada RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Mexico RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Table APAC RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table APAC RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)
Figure APAC RNAi for Therapeutic Market Size Market Share by Countries in 2017
Table APAC RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table APAC RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
Figure APAC RNAi for Therapeutic Market Size Market Share by Type in 2017
Table APAC RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table APAC RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
Figure APAC RNAi for Therapeutic Market Size Market Share by Application in 2017
Figure China RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Japan RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Korea RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure India RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Australia RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Table Europe RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table Europe RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)
Figure Europe RNAi for Therapeutic Market Size Market Share by Countries in 2017
Table Europe RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table Europe RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
Figure Europe RNAi for Therapeutic Market Size Market Share by Type in 2017
Table Europe RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Europe RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
Figure Europe RNAi for Therapeutic Market Size Market Share by Application in 2017
Figure Germany RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure France RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure UK RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Italy RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Russia RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Spain RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Countries in 2017
Table Middle East & Africa RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type in 2017
Table Middle East & Africa RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application in 2017
Figure Egypt RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure South Africa RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Israel RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Turkey RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)
Figure Global RNAi for Therapeutic arket Size Forecast (2018-2023) ($ Millions)
Table Global RNAi for Therapeutic Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Regions
Figure Americas RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure APAC RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Europe RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure United States RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Canada RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Mexico RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Brazil RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure China RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Japan RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Korea RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Southeast Asia RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure India RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Australia RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Germany RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure France RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure UK RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Italy RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Russia RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Spain RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Egypt RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure South Africa RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Israel RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure Turkey RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Figure GCC Countries RNAi for Therapeutic Market Size 2018-2023 ($ Millions)
Table Global RNAi for Therapeutic Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Type (2018-2023)
Table Global RNAi for Therapeutic Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Application (2018-2023)
Table Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)
Table Arbutus Biopharma (Tekmira) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2016-2018)
Table Arrowhead Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arrowhead RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Arrowhead RNAi for Therapeutic Market Share (2016-2018)
Table Dicerna Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)
Table Mirna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2016-2018)
Table Quark Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)
Table RXi Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)
Table Silence Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Silence Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Silence Therapeutics RNAi for Therapeutic Market Share (2016-2018)
Table Benitec Biopharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Benitec Biopharma RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure Benitec Biopharma RNAi for Therapeutic Market Share (2016-2018)
Table miRagen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table miRagen Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2016-2018)
Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2016-2018)
Table Sylentis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gradalis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sirnaomics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Silenseed Basic Information, Head Office, Major Market Areas and Its Competitors
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
